Tcg Crossover Management, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $892 Million distributed in 40 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Cogent Biosciences, Inc. with a value of $97.6M, Amylyx Pharmaceuticals, Inc. with a value of $84.9M, Centessa Pharmaceuticals PLC with a value of $76.1M, Tango Therapeutics, Inc. with a value of $71.7M, and Ocular Therapeutix, Inc with a value of $71.5M.
Examining the 13F form we can see an increase of $402M in the current position value, from $490M to 892M.
Tcg Crossover Management, LLC is based out at Palo Alto, CA
Below you can find more details about Tcg Crossover Management, LLC portfolio as well as his latest detailed transactions.
